Cencora Inc (COR) is slightly overvalued and Cosmos Health Inc (COSM) is undervalued.
Against our estimates of intrinsic value, COSM trades at the wider discount: a margin of safety of +52%, against -20% for COR.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $262.24; the price of $314.43 is 20% above that value, and 80% of that value comes from beyond year five.
Leak Score 57/100 on 10 of 12 signals
A 1.2x revenue multiple, discounted for its losses, values the shares at $0.73; the price of $0.35 is 52% below that value.
Leak Score 56/100 on 2 of 12 signals
| Metric | COR | COSM |
|---|---|---|
| Verdict | Slightly overvalued | Undervalued |
| Price | $314.43 | $0.35 |
| Intrinsic value | $262.24 | $0.73 |
| Margin of safety | -20% | +52% |
| Leak Score | 57/100 (10/12) | 56/100 (2/12) |
| Market cap | $60.0B | $36M |
| Revenue growth, 5 years | 11.1% | 3.3% |
| Operating margin | 1.3% | -24.6% |
| Net margin | 0.8% | -33.1% |
| Return on equity | 104.3% | -104.0% |
| Debt to equity | 3.84 | 0.80 |
| P/E | 23.4x | — |
| Forward P/E | 15.9x | 5.1x |
| P/B | 19.7x | 1.4x |
| Dividend yield | 0.8% | — |